Bookmark and Share
BioAssay: AID 2645

ELISA Cell-Based Screen to Identify Inducers of cAMP in Platelets

Cell-based assay for measurement of platelet cAMP levels. Washed platelets obtained from individual donors were treated with a selection of compounds that were chosen based on activity in an SFLLRN-induced P-selectin expression assay (AID 2518). Prostaglandin E1 (PGE1) at 1 uM was used as a positive control to elevate platelet cAMP levels. Compounds were tested at 10uM. Platelets were lysed more ..
_
   
 Tested Compounds
 Tested Compounds
All(16)
 
 
Active(12)
 
 
Inactive(4)
 
 
 Tested Substances
 Tested Substances
All(16)
 
 
Active(12)
 
 
Inactive(4)
 
 
 Related BioAssays
 Related BioAssays
AID: 2645
Data Source: Broad Institute (2016-05_INHIBITORS_SINGLE-POINT_MLPCN-CHERRYPICK)
BioAssay Type: Primary, Primary Screening, Single Concentration Activity Observed
Depositor Category: NIH Molecular Libraries Probe Production Network, Assay Provider
BioAssay Version:
Deposit Date: 2010-03-23
Hold-until Date: 2010-09-30
Modify Date: 2010-09-30

Data Table ( Complete ):           View Active Data    View All Data
BioActive Compounds: 12
Related Experiments
Show more
AIDNameTypeProbeComment
1663MLPCN Platelet Activation -Dense Granule ReleaseScreening depositor-specified cross reference: Primary HTS
1678Broad Institute MLPCN Platelet ActivationSummary3 depositor-specified cross reference: Project Summary
2518Fluorescence Cell-Based Dose Response to Identify Inhibitors of Thrombin Receptor-Activating Peptide SFLLRN-Mediated P-Selectin Induction on Platelets.Confirmatory depositor-specified cross reference: Assay describing the ability of compounds to inhibit SFLLRN-induced P-selectin expression on platele
1889Luminescence Cell-Based Dose Confirmation HTS to Identify Inhibitors of Platelet Dense Granule ReleaseConfirmatory same project related to Summary assay
1891Luminescence Biochemical Dose Response HTS to Identify Inhibitors of LuciferaseConfirmatory same project related to Summary assay
2398Luminescence Cell-Based Dose Response Followup to Identify Inhibitors of Platelet Dense Granule ReleaseConfirmatory same project related to Summary assay
2509Fluorescence Cell-Based Screen to Identify Inhibitors of Phorbol Myristate Acetate-Mediated P-Selectin Induction on PlateletsScreening same project related to Summary assay
2511Fluorescence Cell-Based Dose Response to Confirm Inhibitors of Thrombin Receptor-Activating Peptide SFLLRN-Mediated P-Selectin Induction on PlateletsConfirmatory same project related to Summary assay
2519Luminescence Cell-Based Dose Response Followup to Identify Inhibitors of Platelet Dense Granule Release.Confirmatory same project related to Summary assay
2522Fluorescence Cell-Based Screen to Identify Inhibitors of Calcium Ionophore-Mediated P-Selectin Induction on PlateletsScreening same project related to Summary assay
2527Fluorescence Cell-Based Screen to Confirm Inhibitors of Calcium Ionophore-Mediated P-Selectin Induction on PlateletsScreening same project related to Summary assay
2529Fluorescence Cell-Based Screen to Confirm Inhibitors of Phorbol Myristate Acetate-Mediated P-Selectin Induction on PlateletsScreening same project related to Summary assay
2646ELISA Cell-Based Screen to Identify an Inducer of cAMP in PlateletsScreening same project related to Summary assay
2655Fluorescence Cell-Based Screen to Identify an Inhibitor of Thrombin Receptor-Activating Peptide SFLLRN-Mediated Actin Polymerization in PlateletsScreening same project related to Summary assay
2656Radioactive Cell-Based Screen to Identify Inhibitors of Thrombin Receptor-Activating Peptide SFLLRN-Mediated Dense Granule Release by PlateletsScreening same project related to Summary assay
2657Fluorescence Cell-Based Screen to Identify Inhibitors of Thrombin Receptor-Activating Peptide SFLLRN-Mediated Actin Polymerization in PlateletsScreening same project related to Summary assay
493031SFLLRN-induced P-Selectin Platelet Surface Expression Measured in Cell-Based System Using Flow Cytometry - 2016-03_Inhibitor_SinglePoint_DryPowder_ActivityOther same project related to Summary assay
493068SFLLRN-induced P-Selectin Platelet Surface Expression Measured in Cell-Based System Using Flow Cytometry - 2016-03_Inhibitor_Dose_DryPowder_Activity_Set3Confirmatory same project related to Summary assay
493100Platelet granule secretion Measured in Cell-Based System Using Plate Reader - 2016-01_Inhibitor_Dose_DryPowder_ActivityConfirmatory same project related to Summary assay
Description:
Keywords: Platelet, cAMP, PGE1, competitive ELISA

Assay Overview:
Cell-based assay for measurement of platelet cAMP levels. Washed platelets obtained from individual donors were treated with a selection of compounds that were chosen based on activity in an SFLLRN-induced P-selectin expression assay (AID 2518). Prostaglandin E1 (PGE1) at 1 uM was used as a positive control to elevate platelet cAMP levels. Compounds were tested at 10uM. Platelets were lysed following compound or control incubation, and lysates were analyzed with a cAMP competitive ELISA kit (Thermo Scientific). Values were converted to cAMP concentration (pmol/mL) based on a cAMP standard curve measured in parallel.

Expected Outcome:
This assay was performed as a counterscreen to select against compounds that elevate cAMP levels, since many available platelet activation inhibitors are capable of elevating platelet cAMP levels. Levels of cAMP induced by treatment with compounds were compared to high levels induced by treatment with positive control PGE1. Compounds that raised cAMP levels to less than 50% of the PGE1 control were considered inactive and selected for additional assays to determine specificity in ability to inhibit platelet activation.

Primary Collaborators(and laboratory where assay was performed):
Robert Flaumenhaft, Beth Israel Deaconess Medical Center, rflaumen@bidmc.harvard.edu, 617-754-1204
John Thomas, NHLBI, ThomasJ@nhlbi.nih.gov
Protocol
1. Platelet samples (100 ul) were incubated with 1 uM PGE1 (positive control), or 10 uM compound, or 0.3% DMSO (neutral control).

2. After a 5-minute incubation, platelets were lysed in 0.1M HCL/0.5% Triton X-100 buffer.

3. The platelet lysates were evaluated using a commercially available competitive ELISA to quantitate cAMP (Thermo Scientific; Catalog Number EMSCAMPL).

4. A dose curve of known concentrations of cAMP standard was prepared and measured in parallel using the ELISA. cAMP levels in samples were quantitated in pmol/mL by fitting optical density readings to the standard curve.

5. cAMP levels in duplicate samples from platelets exposed to compounds were compared to cAMP levels from platelets exposed to PGE1.
Comment
Data Analysis:
The neutral control was DMSO only, with no compound, in duplicate.
The positive control was PGE1 at 1 uM, in duplicate.
Compounds were tested at 10 uM, in duplicate.

PGE1-induced cAMP was calculated as:
Mean pmol/mL with PGE1 - Mean pmol/mL with DMSO

Compound-induced cAMP was calculated as:
Mean pmol/mL with compound - Mean pmol/mL with DMSO

Percent of PGE1-induced cAMP (Percent Activity) was calculated as:
100 * (Compound-induced cAMP at 10uM / PGE1-induced cAMP)


PUBCHEM_ACTIVITY_SCORE
The Percent Activity across two replicates. Negative values were adjusted to be zero. Values greater than 100 were adjusted to be 100.

PUBCHEM_ACTIVITY_OUTCOME
Activity_Outcome = 1 (inactive)
PUBCHEM_ACTIVITY_SCORE <= 50

Activity_Outcome = 2 (active)
PUBCHEM_ACTIVITY_SCORE > 50
Result Definitions
TIDNameDescriptionHistogramTypeUnit
OutcomeThe BioAssay activity outcomeOutcome
ScoreThe BioAssay activity ranking scoreInteger
1Percent ActivityPercent of PGE1-induced cAMPFloat%
Additional Information
Grant Number: 1R03DA026209-01

Data Table (Concise)
Data Table ( Complete ):     View Active Data    View All Data
PageFrom: